DelNova to be featured in the upcoming list of Top 10 Biotech Startups 2022 as Editor’s Choice, on Life Sciences Review Magazine...
DelNova announces advances in the development of the First ever product to reverse complications arising from botulinum toxins, such as BOTOX®, Dysport®, XEOMIN®,...
StartEngine allows anyone to invest in startups, private companies, and collectibles - like trading cards, comic books, and even fine wine! Now you...
Steve Yoelin, M.D. is a board-certified ophthalmologist based in Orange County, CA, with approximately 20 years of experience in minimally invasive medical aesthetics,...
DelNova’s patent portfolio covers key markets worldwide....
Watch the video presentation....
Presentation to highlight ReViVox™, DelNova's lead product candidate designed for treating complications resulting from undesirable muscle paralysis following botulinum neurotoxin (e.g. Botox®) procedures SAN...
